Literature DB >> 4417621

Normal glomerular permeability and its modification by minimal change nephrotic syndrmone.

A M Robson, J Giangiacomo, R A Kienstra, S T Naqvi, J R Ingelfinger.   

Abstract

It has been suggested that the glomerular basement membrane restricts the passage of large molecules only, the barrier to filtration of smaller molecules being at the level of the epithelial slit pore. This hypothesis was investigated by measuring glomerular permeability to (125)I-labeled polydisperse polyvinyl pyrrolidone (PVP) in 16 children with idiopathic nephrotic syndrome (INS) and in 6 children of comparable age who had no evidence of renal disease. Studies were performed in the patients with INS before, during, and after treatment with steroids. PVP in blood and urine samples was separated according to molecular size by solumn chromatography, to permit the calculation of permeability to inert macromolecules of sizes ranging from 8,000 mol wt. In untreated INS, glomerular permeability to molecules > 40 A was normal; permeability to smaller molecules was markedly reduced, frequently to 20% or less of normal. There was an average decrease in inulin clearance (C(in)) of 24%. Glomerular permeability and C(in) returned to normal in INS treated with steroids only when proteinuria disappeared. The results support the concept, derived from studies with ultrastructural tracers, that the final barrier to filtration may be at the level of the epithelial slit pore. Thus fusion of the epithelial foot processed with obliteration of the slit pores was associated with impaired passage of smaller molecules of PVP into the urine. Reversal of the pathologic abnormality resulted in return of permeability to normal. The decreased C(in) seen in INS may not reflect true glomerular filtration rate, but may result from restricted passage of inulin molecules (mol wt 5,000) through the epithelial slit pore.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4417621      PMCID: PMC301666          DOI: 10.1172/JCI107862

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  MOLECULAR EXCLUSION AND RESTRICTED DIFFUSION PROCESSES IN MOLECULAR-SIEVE CHROMATOGRAPHY.

Authors:  G K ACKERS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

2.  ENDOGENOUS-CREATININE CLEARANCE AND GLOMERULAR-FILTRATION RATE.

Authors:  G M BERLYNE; H VARLEY; S NILWARANGKUR; M HOERNI
Journal:  Lancet       Date:  1964-10-24       Impact factor: 79.321

3.  SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME.

Authors:  G R JOACHIM; J S CAMERON; M SCHWARTZ; E L BECKER
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

4.  Fine structural alterations in the rat kidney following intraperitoneal bovine albumin.

Authors:  M S ANDERSON; L RECANT
Journal:  Am J Pathol       Date:  1962-05       Impact factor: 4.307

5.  Determination of inulin in plasma and urine by use of anthrone.

Authors:  R P WHITE; F E SAMSON
Journal:  J Lab Clin Med       Date:  1954-03

6.  Renal clearances of grass polysaccharide: observations on glomerular porosity and on the relation of this function to proteinuria in renal disease.

Authors:  J BEATTIE; A C CORCORAN
Journal:  J Clin Invest       Date:  1952-05       Impact factor: 14.808

7.  Glomerular basement membrane in experimental nephrosis: chemical composition.

Authors:  R P Misra; N Kalant
Journal:  Nephron       Date:  1966       Impact factor: 2.847

8.  Human glomerular membrane porosity and filtration pressure: dextran clearance data analysed by theoretical models.

Authors:  G Arturson; T Groth; G Grotte
Journal:  Clin Sci       Date:  1971-02       Impact factor: 6.124

9.  Glomerular polyanion. Alteration in aminonucleoside nephrosis.

Authors:  A F Michael; E Blau; R L Vernier
Journal:  Lab Invest       Date:  1970-12       Impact factor: 5.662

10.  Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers.

Authors:  R C Graham; M J Karnovsky
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

View more
  21 in total

Review 1.  The podocyte slit diaphragm--from a thin grey line to a complex signalling hub.

Authors:  Florian Grahammer; Christoph Schell; Tobias B Huber
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.

Authors:  M P Bohrer; C Baylis; C R Robertson; B M Brenner; J L Troy; W T Willis
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 3.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 4.  Mechanisms of proteinuria in nephrotic humans.

Authors:  B D Myers; A Guasch
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

5.  Nephrotic syndrome.

Authors:  M G Cogan
Journal:  West J Med       Date:  1982-05

Review 6.  Intra- and extrarenal factors of oedema formation in the nephrotic syndrome.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.

Authors:  Y Fujiwara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Glomerular selective permeability to macromolecular neutral dextrans in experimental diabetes.

Authors:  J P Pennell; N Yanagawa; K H Hwang; M M Millard; J J Bourgoignie
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

Review 9.  Low molecular weight proteins in children with renal disease.

Authors:  P A Tomlinson
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

10.  Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria.

Authors:  E H Garin
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.